The Combiotic-Study — GOLFIII

Healthy Term Infants Clinical Trial

Official title:
Evaluation of the Efficacy and Safety of an Infant Formula Containing Synbiotics and Its Effects on the Incidence of Infectious Diseases in the Infant Gut : a Double-blind, Randomized, Controlled Interventional Study

Status Terminated

Clinical Trial Summary

The primary objective of this study is to demonstrate that a synbiotic formula, fed for the duration of the first year of life (infant and follow-on formula) reduces the incidence rate of episodes of infectious diarrhea in infants during the first year of life compared to a standard infant formula.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Healthy Term Infants

Clinical Trial Details

NCT number	NCT02221687
Study type	Interventional
Source	HiPP GmbH & Co. Vertrieb KG
Contact
Status	Terminated
Phase	N/A
Start date	August 2014
Completion date	April 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02646969` - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life	N/A
Terminated	`NCT01137877` - Growth and Tolerance of Healthy Term Infants to a New Infant Formula	Phase 3
Completed	`NCT01155414` - Tolerance of Healthy Term Infants Fed Infant Formulas #4	Phase 3
Completed	`NCT04015050` - Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.	N/A
Completed	`NCT01497314` - Growth and Safety of a Low Lactose Milk-Based Infant Formula	N/A
Completed	`NCT00712608` - The Evaluation of Cow's Milk Formula - Study B	N/A